Name: COBRA
What kind of cancer is this for: Multiple Myeloma
Phase: III
Who is this trial for? Men and women who have just found out that they have multiple myeloma
What biomarkers are involved? None
What is National Clinical Trial#? NCT03729804
Brief summary of trial: This trial is looking at which treatment plan works better at 12 and 24 months after starting.
Need to know: Both transplant and non-transplant candidates are eligible. Transplant candidates must agree at the time of consent to defer transplant to the end of study treatment.
Where is this trial available? The Cancer & Hematology Centers
For more information, please call 616-975-3065 or email [email protected]